Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (221-230 of 627) with videos related to

Pageof 63
Sort By:
Circulation|December 16, 2014
Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Eric D Peterson, Sunghee Kim, et al.
Journal of the American Heart Association|December 24, 2017
Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)Kevin L Thomas, Larry R Jackson, Peter Shrader, et al.
European Heart Journal|June 30, 2007
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysisSabina A Murphy, Charles Michael Gibson, David A Morrow, et al.
JAMA|April 24, 2008
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialGregg W Stone, Mark Midei, William Newman, et al.
Circulation. Cardiovascular Interventions|May 31, 2015
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularizationAkshay Bagai, Zhen Huang, Yuliya Lokhnygina, et al.
American Heart Journal|December 15, 2010
Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: a pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGYMark Y Chan, Jie L Sun, Tracy Y Wang, et al.
Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.
Diabetologia|August 20, 2021
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trialTaha Sen, Jingwei Li, Brendon L Neuen, et al.
American Heart Journal|April 30, 2017
An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndromeNeha J Pagidipati, Connie N Hess, Robert M Clare, et al.
Journal of the American College of Cardiology|November 6, 2012
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarctionSergio Leonardi, Laine Thomas, Megan L Neely, et al.
Pageof 63

Showing results (221-230 of 627) with videos related to

Sort By:
Pageof 63
Circulation|December 16, 2014
Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Eric D Peterson, Sunghee Kim, et al.
Journal of the American Heart Association|December 24, 2017
Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)Kevin L Thomas, Larry R Jackson, Peter Shrader, et al.
European Heart Journal|June 30, 2007
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysisSabina A Murphy, Charles Michael Gibson, David A Morrow, et al.
JAMA|April 24, 2008
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialGregg W Stone, Mark Midei, William Newman, et al.
Circulation. Cardiovascular Interventions|May 31, 2015
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularizationAkshay Bagai, Zhen Huang, Yuliya Lokhnygina, et al.
American Heart Journal|December 15, 2010
Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: a pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGYMark Y Chan, Jie L Sun, Tracy Y Wang, et al.
Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.
Diabetologia|August 20, 2021
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trialTaha Sen, Jingwei Li, Brendon L Neuen, et al.
American Heart Journal|April 30, 2017
An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndromeNeha J Pagidipati, Connie N Hess, Robert M Clare, et al.
Journal of the American College of Cardiology|November 6, 2012
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarctionSergio Leonardi, Laine Thomas, Megan L Neely, et al.
Pageof 63